Fresh2 Group Limited is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2023. With two certified clinical laboratories in China and one CLIA and CAP accredited clinical laboratory in the United States, Fresh2 performs a suite of cancer screening and detection tests, including CDA (Cancer Differentiation Analysis), bio-chemical, immunological, and genomics tests. The Company is entering the business-to-business e-commerce food business with the formation of its wholly-owned subsidiary Fresh2 Technology Inc and the acquisition of Fresh2 Ecommerce Inc.
![Fresh2 logo](/files/LOGO/1786511-placeholder.png)
Company profile
Ticker
FRES
Exchange
Website
CEO
Chang Yu
Employees
Incorporated
Location
Sector
Industry (SIC)
Quest Diagnostics • Labcorp • Fortrea • Radnet • Akumin • Burning Rock Biotech • Guardant Health • Exact Sciences • Genomic Health • Invitae ...
Former names
AnPac Bio-Medical Science Co., Ltd.
SEC CIK
FRES stock data
Latest filings (excl ownership)
6-K
Report of Foreign Private Issuer
24 Jul 24
8-K
Fresh2 Group Limited Announces Plan to Implement ADS Ratio Change
26 Jun 24
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
24 Jun 24
8-K
Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
23 May 24
8-K
Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
22 Apr 24
8-K
Entry into a Material Definitive Agreement
2 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
8-K
Entry into a Material Definitive Agreement
27 Mar 24
8-K
Entry into a Material Definitive Agreement
25 Mar 24
8-K
Entry into a Material Definitive Agreement
25 Mar 24
Transcripts
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q1 2024
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 14.21 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
ST Fortune | 14.21 mm | $0.00 |
News
Fresh2 Has Partnered With Over 50 Influencers, Leveraging Key Partnerships To Fresh2's Video E-Commerce Business Is Rapidly Expanding Its Market Presence In The E-Commerce Sector
16 Jul 24
Fresh2 Group Limited Announces 1-For-10 Reverse ADS Split, Expected To Become Effective On July 10, 2024
8 Jul 24
12 Health Care Stocks Moving In Monday's After-Market Session
17 Jun 24
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
6 Jun 24
12 Health Care Stocks Moving In Thursday's Intraday Session
6 Jun 24